(3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate, 97.0%, 250mg

Ethyl 4-(trifluoromethoxy)cyclohexane-1-carboxylate, 98%, 5g

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

1-(1-ethyl-1H-imidazol-2-yl)methanamine, 95.0%, 5g

4,6-Diphenyl-1-[(E)-(phenylmethylidene)amino]-1,2-dihydropyridin-2-one, 1g

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, 98.0%, 1g

Tellurium powder 99.999% 100 g

N-Hydroxy-5-norbornene-2,3-dicarboximide [for Peptide Synthesis]>99.0%(T)25g

2-(2-Chlorophenoxy)benzoic acid, 97%, 250mg

Methyl 3-bromo-4-formylbenzoate, 95.0%, 250mg

8-Bromo-6-methoxy-tetralin-1-one, 98%, 500mg

1-(2,5-Difluoro-phenyl)-2,2,2-trifluoro-ethanone, 98%, 250mg

4,4'-(Ethane-1,2-diylbis(oxy))dianiline, 95.0%, 10g